MULTIPLE MYELOMA KNOWLEDGE CENTER

Get the Facts

Find what you need to know
in our brochures.

DOWNLOAD

Speak to an MMRF
nurse specialist

An MMRF nurse specialist can
guide you through your multiple
myeloma journey every step of the
way. Call Monday-Friday, 9-7 ET.

CALL NOW

What is Kyprolis?

Kyprolis, also known as carfilzomib, is a next generation proteasome inhibitor in the same drug class as Velcade.

The MMRF and it’s affiliate organization, the Multiple Myeloma Research Consortium (MMRC), played an integral role in the development of Kyprolis over the past 6 years. The MMRC provided clinical trial support and resources, including driving patient enrollment to the study which lead to the approval of Kyprolis for treating multiple myeloma. Download Kyprolis brochure.